Summary by Moomoo AI
Sai Sang Pharmaceutical Holdings Limited (“Sai Sai Pharma”) announced on 19 March 2024 that, at the Company's request, its shares will be suspended briefly on the Hong Kong Stock Exchange Limited from 9.07am on the same day. The move was to issue an announcement containing an inside information about the Company's Code of Acquisitions and Mergers. Mr. Zhao Hong, the Executive Director, Chief Executive Officer and President of Sai Sang Pharmaceuticals issued this announcement on the same day on behalf of the Board of Directors. Board members also include Ms. Pan Rung-yong, Mr. Li Zhenfu, Dr. Daniel Luzius Vasella, Ms. Lin Shirley Yi-Hsien, Ms. Wang Haixia, as well as Independent Non-Executive Directors Dr. Liu Kwok Yan, Dr. Chen Ping, Mr. Gu Alex Yushao and Ms. Wendy Hayes.